He received his BSc (Pharmacy) with first class honors from NUS in 2000. Subsequently, he obtained his PhD in medicinal chemistry from the University of Washington in 2005, investigating the molecular mechanisms of specific drug-induced liver toxicity. After that, he returned to Singapore for a 3-year postdoctoral fellowship investigating the roles of tyrosine kinases for various malignancies. Presently, he directs a toxicology division within the Drug Development Unit at NUS. He has published more than 40 papers in internationally recognized journals and has won multiple university-level teaching excellence awards.